David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Allegion
ALLE
$13.7B
| $490K | ﹤0.01% |
3,870
-16,769
| -81% | -$1.79M |
|
3377
Ryman Hospitality Properties
RHP
$9.06B
| $489K | ﹤0.01% |
4,445
-20,181
| -82% | -$1.92M |
|
3378
iShares MSCI USA Quality Factor ETF
QUAL
$47.8B
| $487K | ﹤0.01% |
+3,312
| New | +$458K |
|
3379
SLR Investment Corp
SLRC
$687M
| $483K | ﹤0.01% |
+32,137
| New | +$479K |
|
3380
CALL
AST SpaceMobile
ASTS
$18.6B
| $482K | ﹤0.01% |
80,000
| – | – |
|
|
GCMGW
3381
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
| $482K | ﹤0.01% |
1,338,942
+496,525
| +59% | +$158K |
|
3382
Tecnoglass Holdings
TGLS
$1.81B
| $482K | ﹤0.01% |
+10,542
| New | +$381K |
|
3383
PUT
Transocean
RIG
$6.42B
| $481K | ﹤0.01% |
75,800
-358,200
| -83% | -$2.4M |
|
3384
Graco
GGG
$12.9B
| $478K | ﹤0.01% |
5,505
-17,942
| -77% | -$1.41M |
|
3385
CALL
Conagra Brands
CAG
$7.76B
| $476K | ﹤0.01% |
16,600
+6,000
| +57% | +$168K |
|
3386
Ternium
TX
$10.8B
| $475K | ﹤0.01% |
+11,189
| New | +$433K |
|
3387
PUT
ZTO Express
ZTO
$16.2B
| $475K | ﹤0.01% |
22,300
-55,000
| -71% | -$1.25M |
|
3388
TPG
TPG
$8.77B
| $472K | ﹤0.01% |
10,925
-16,018
| -59% | -$541K |
|
3389
Schneider National
SNDR
$6.11B
| $469K | ﹤0.01% |
18,429
-89,285
| -83% | -$2.2M |
|
3390
Liberty Latin America Class C
LILAK
$1.67B
| $468K | ﹤0.01% |
70,178
+38,388
| +121% | +$249K |
|
|
WKME
3391
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $468K | ﹤0.01% |
43,862
+9,552
| +28% | +$90K |
|
3392
PennantPark Floating Rate Capital
PFLT
$735M
| $468K | ﹤0.01% |
38,674
+26,631
| +221% | +$291K |
|
3393
Dropbox
DBX
$7.51B
| $467K | ﹤0.01% |
15,858
-82,800
| -84% | -$2.3M |
|
|
GBIO
3394
DELISTED
Generation Bio
GBIO
| $467K | ﹤0.01% |
28,311
+25,812
| +1,033% | +$450K |
|
3395
C3.ai
AI
$1.55B
| $466K | ﹤0.01% |
16,245
+1,199
| +8% | +$33K |
|
3396
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $466K | ﹤0.01% |
+11,370
| New | +$431K |
|
|
CLDT
3397
Chatham Lodging
CLDT
$637M
| $466K | ﹤0.01% |
43,427
-56,785
| -57% | -$567K |
|
3398
Aemetis
AMTX
$139M
| $465K | ﹤0.01% |
88,714
+26,107
| +42% | +$123K |
|
3399
IQVIA
IQV
$42.6B
| $463K | ﹤0.01% |
2,000
-1,200
| -38% | -$246K |
|
3400
Gossamer Bio
GOSS
$96.9M
| $463K | ﹤0.01% |
506,888
+235,578
| +87% | +$174K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.